<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Metabolites</journal-id><journal-id journal-id-type="iso-abbrev">Metabolites</journal-id><journal-id journal-id-type="pmc-domain-id">2273</journal-id><journal-id journal-id-type="pmc-domain">metabolites</journal-id><journal-id journal-id-type="publisher-id">metabolites</journal-id><journal-title-group><journal-title>Metabolites</journal-title></journal-title-group><issn pub-type="epub">2218-1989</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC9784906</article-id><article-id pub-id-type="pmcid-ver">PMC9784906.1</article-id><article-id pub-id-type="pmcaid">9784906</article-id><article-id pub-id-type="pmcaiid">9784906</article-id><article-id pub-id-type="pmid">36557243</article-id><article-id pub-id-type="doi">10.3390/metabo12121205</article-id><article-id pub-id-type="publisher-id">metabolites-12-01205</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Mannose Receptor Deficiency Impacts Bone Marrow and Circulating Immune Cells during High Fat Diet Induced Obesity</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Nour</surname><given-names initials="J">Jasmine</given-names></name><xref rid="af1-metabolites-12-01205" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Moregola</surname><given-names initials="A">Annalisa</given-names></name><xref rid="af1-metabolites-12-01205" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7269-7308</contrib-id><name name-style="western"><surname>Svecla</surname><given-names initials="M">Monika</given-names></name><xref rid="af1-metabolites-12-01205" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6298-8689</contrib-id><name name-style="western"><surname>Da Dalt</surname><given-names initials="L">Lorenzo</given-names></name><xref rid="af1-metabolites-12-01205" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2595-7226</contrib-id><name name-style="western"><surname>Bellini</surname><given-names initials="R">Rossella</given-names></name><xref rid="af1-metabolites-12-01205" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Neyrolles</surname><given-names initials="O">Olivier</given-names></name><xref rid="af2-metabolites-12-01205" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fadini</surname><given-names initials="GP">Gian Paolo</given-names></name><xref rid="af3-metabolites-12-01205" ref-type="aff">3</xref><xref rid="af4-metabolites-12-01205" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4482-2199</contrib-id><name name-style="western"><surname>Rombouts</surname><given-names initials="Y">Yoann</given-names></name><xref rid="af2-metabolites-12-01205" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Albiero</surname><given-names initials="M">Mattia</given-names></name><xref rid="af3-metabolites-12-01205" ref-type="aff">3</xref><xref rid="af4-metabolites-12-01205" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2611-1177</contrib-id><name name-style="western"><surname>Bonacina</surname><given-names initials="F">Fabrizia</given-names></name><xref rid="af1-metabolites-12-01205" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6081-1257</contrib-id><name name-style="western"><surname>Norata</surname><given-names initials="GD">Giuseppe Danilo</given-names></name><xref rid="af1-metabolites-12-01205" ref-type="aff">1</xref><xref rid="af5-metabolites-12-01205" ref-type="aff">5</xref><xref rid="c1-metabolites-12-01205" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Park</surname><given-names initials="JH">Julien H.</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name name-style="western"><surname>Marquardt</surname><given-names initials="T">Thorsten</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-metabolites-12-01205"><label>1</label>Department of Excellence of Pharmacological and Biomolecular Sciences, University of Milan, 20133 Milan, Italy</aff><aff id="af2-metabolites-12-01205"><label>2</label>Institut de Pharmacologie et de Biologie Structurale, IPBS, University of Toulouse, CNRS, UPS, 31400 Toulouse, France</aff><aff id="af3-metabolites-12-01205"><label>3</label>Department of Medicine, University of Padua, 35128 Padua, Italy</aff><aff id="af4-metabolites-12-01205"><label>4</label>Veneto Institute of Molecular Medicine, 35129 Padua, Italy</aff><aff id="af5-metabolites-12-01205"><label>5</label>Centro SISA Per lo Studio Dell&#8217;Aterosclerosi, Ospedale Bassini, 20092 Cinisello Balsamo, Italy</aff><author-notes><corresp id="c1-metabolites-12-01205"><label>*</label>Correspondence: <email>danilo.norata@unimi.it</email></corresp></author-notes><pub-date pub-type="epub"><day>01</day><month>12</month><year>2022</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2022</year></pub-date><volume>12</volume><issue>12</issue><issue-id pub-id-type="pmc-issue-id">424348</issue-id><elocation-id>1205</elocation-id><history><date date-type="received"><day>18</day><month>10</month><year>2022</year></date><date date-type="accepted"><day>21</day><month>11</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>12</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>24</day><month>12</month><year>2022</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-08 20:25:25.920"><day>08</day><month>09</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2022 by the authors.</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="metabolites-12-01205.pdf"/><abstract><p>The mannose receptor C-type 1 (Mrc1) is a C-type lectin receptor expressed on the immune cells and sinusoidal endothelial cells (ECs) of several tissues, including the bone marrow (BM). Parallel to systemic metabolic alterations and hematopoietic cell proliferation, high-fat diet (HFD) feeding increases the expression of Mrc1 in sinusoidal ECs, thus calling for the investigation of its role in bone marrow cell reprogramming and the metabolic profile during obesity. <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice and wild-type (WT) littermates were fed an HFD (45% Kcal/diet) for 20 weeks. Weight gain was monitored during the diet regimen and glucose and insulin tolerance were assessed. Extensive flow cytometry profiling, histological, and proteomic analyses were performed. After HFD feeding, <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice presented impaired medullary hematopoiesis with reduced myeloid progenitors and mature cells in parallel with an increase in BM adipocytes compared to controls. Accordingly, circulating levels of neutrophils and pro-inflammatory monocytes decreased in <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice together with reduced infiltration of macrophages in the visceral adipose tissue and the liver compared to controls. Liver histological profiling coupled with untargeted proteomic analysis revealed that <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice presented decreased liver steatosis and the downregulation of proteins belonging to pathways involved in liver dysfunction. This profile was reflected by improved glucose and insulin response and reduced weight gain during HFD feeding in <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice compared to controls. Our data show that during HFD feeding, mannose receptor deficiency impacts BM and circulating immune cell subsets, which is associated with reduced systemic inflammation and resistance to obesity development.</p></abstract><kwd-group><kwd>Mrc1</kwd><kwd>obesity</kwd><kwd>bone marrow</kwd><kwd>inflammation</kwd></kwd-group><funding-group><award-group><funding-source>Fondazione Cariplo</funding-source><award-id>2019&#8211;1560</award-id></award-group><award-group><funding-source>Telethon Foundation</funding-source><award-id>GGP19146</award-id></award-group><award-group><funding-source>Progetti di Rilevante Interesse Nazionale</funding-source><award-id>PRIN 2017 K55HLC</award-id></award-group><award-group><funding-source>Ricerca Finalizzata, Ministry of Health</funding-source><award-id>RF-2019-12370896</award-id></award-group><award-group><funding-source>PNRR</funding-source><award-id>M4C2-Investimento 1.4- CN00000041</award-id></award-group><funding-statement>The work is supported by: Fondazione Cariplo [2019&#8211;1560] and Roche Per la Ricerca 2021 to F.B.; Telethon Foundation [GGP19146], Progetti di Rilevante Interesse Nazionale [PRIN 2017 K55HLC], Ricerca Finalizzata, Ministry of Health [RF-2019-12370896], PNRR [M4C2-Investimento 1.4- CN00000041] to G.D.N.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-metabolites-12-01205"><title>1. Introduction</title><p>The mannose receptor (Mrc1) is a unique type 1 transmembrane receptor that is a member of the C-type lectin family. Mrc1 can be located on non-vascular endothelium, macrophages [<xref rid="B1-metabolites-12-01205" ref-type="bibr">1</xref>], and dendritic cells [<xref rid="B2-metabolites-12-01205" ref-type="bibr">2</xref>] as well as in the serum in a shortened soluble form [<xref rid="B3-metabolites-12-01205" ref-type="bibr">3</xref>]. It presents eight C-type lectin domains (CTLDs), of which only number four is functional, and recognizes mannose, fucose, and N-acetylglucosamine (GlcNac) [<xref rid="B4-metabolites-12-01205" ref-type="bibr">4</xref>]. Moreover, Mrc1 has a fibronectin type II (FNII) domain with a high affinity for collagen [<xref rid="B5-metabolites-12-01205" ref-type="bibr">5</xref>], and a terminal cysteine-rich (CR) domain which binds sulfated sugars [<xref rid="B6-metabolites-12-01205" ref-type="bibr">6</xref>]. </p><p>Because of its complex structure, the mannose receptor recognizes several ligands, including circulating hormones [<xref rid="B7-metabolites-12-01205" ref-type="bibr">7</xref>,<xref rid="B8-metabolites-12-01205" ref-type="bibr">8</xref>] and adhesion molecules [<xref rid="B9-metabolites-12-01205" ref-type="bibr">9</xref>]. This aspect, together with its wide expression, allows Mrc1 to be involved in several processes including the immune response. It has been proposed that Mrc1 plays a key role during the immune response because of its ability to recognize mannose residues [<xref rid="B10-metabolites-12-01205" ref-type="bibr">10</xref>], expressed as terminal glycan moiety on lysosomal enzymes released during inflammation [<xref rid="B11-metabolites-12-01205" ref-type="bibr">11</xref>] or as part of microbial walls [<xref rid="B12-metabolites-12-01205" ref-type="bibr">12</xref>], and because of its participation in leukocyte trafficking. The mannose receptor expressed on sinusoidal endothelial cells interacts with the highly glycosylated protein CD44 on lymphocytes, directly regulating their trafficking [<xref rid="B9-metabolites-12-01205" ref-type="bibr">9</xref>]. Notably, Mrc1 is also expressed in the bone marrow compartment by both macrophages [<xref rid="B13-metabolites-12-01205" ref-type="bibr">13</xref>] and sinusoidal endothelium [<xref rid="B14-metabolites-12-01205" ref-type="bibr">14</xref>], which are known to modulate both the proliferation/maturation of hematopoietic stem cells and the extravasation of immune cells [<xref rid="B15-metabolites-12-01205" ref-type="bibr">15</xref>]. </p><p>Conditions that cause systemic inflammation, such as metabolic disturbances and obesity [<xref rid="B16-metabolites-12-01205" ref-type="bibr">16</xref>], impair bone marrow hematopoiesis and promote the production of pro-inflammatory mediators by sinusoidal ECs [<xref rid="B17-metabolites-12-01205" ref-type="bibr">17</xref>]. The outcomes of these conditions also activate an immune inflammatory response within several target tissues, including the adipose tissue and the liver. The aims of our study were to investigate (1) the role of the mannose receptor in the bone marrow during obesity development and (2) the relationship between the mannose receptor function and changes in systemic inflammation. We fed <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> and control WT mice a high-fat diet (HFD) for 20 weeks and observed that Mrc1 deficiency resulted in reduced myelopoiesis associated with an increased adipocyte count in the bone marrow. This was associated with a significant reduction of circulating myeloid inflammatory cells together with a reduced infiltration of monocyte-derived macrophages in visceral adipose tissue (VAT) and in the liver. The improved inflammatory response in Mrc1-deficient mice was paralleled by reduced body weight gain during HFD feeding, reduced liver steatosis, and improved glucose and insulin response compared to WT mice. These data suggest that the mannose receptor could be involved in the development of the immunometabolic response associated with diet-induced obesity.</p></sec><sec id="sec2-metabolites-12-01205"><title>2. Materials and Methods</title><p>Extensive details of the materials and methods used in our study are provided as an online supplement.</p><sec id="sec2dot1-metabolites-12-01205"><title>2.1. Mice </title><p><italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice on a C57BL/6J background were used and compared to age-matched C57BL/6J wild-type littermates. Four animals were housed per cage and kept in a temperature-controlled environment (20 &#177; 2&#176;C, 50 &#177; 5% relative humidity) with a 12 h light/dark cycle and free access to food and water. Six- to 8-week-old male mice were fed a high-fat diet (HFD, 45% Kcal from fat, Cat. No. D12451, Research diets Inc., New Brunswick, NJ, USA) for 20 weeks. Weight gain was measured weakly. All mice were sacrificed after overnight fasting using isoflurane (2%) inhalation, and then blood was collected using an intracardiac puncture. We also collected and weighed visceral adipose tissue (VAT), subcutaneous adipose tissue (SCAT), brown adipose tissue (BAT) and the liver, femurs, and tibias from the mice. All animal procedures conformed to the guidelines from directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes and were approved by the Ethical Committee (Progetto di Ricerca 2012/02, Autorizzazione Ministeriale 929/2020).</p></sec><sec id="sec2dot2-metabolites-12-01205"><title>2.2. Glucose and Insulin Tolerance Tests</title><p>The glucose tolerance test (GTT) and insulin tolerance test (ITT) were used to measure the plasmatic clearance of glucose after intraperitoneal injection of glucose or insulin, respectively. For the GTT, animals were fasted overnight (approximately 14 h) and then blood glucose levels were measured at fasting and after 20, 40, 60, and 120 min from the injection of a glucose solution (10% <italic toggle="yes">w</italic>/<italic toggle="yes">v</italic> in physiological solution, 1 mg per gram of body weight). Blood glucose levels were measured with a glucometer (ONE-TOUCH Ultra glucometer, Lifescan, Milpitas, CA, USA). For the ITT, animals were fasted for 4 h and then glucose plasma levels were measured at fasting and after 20, 40, 60, and 120 min from the injection of human recombinant insulin (0.75 mU per gram of body weight, Humulin R U-100, 100 U/mL).</p></sec><sec id="sec2dot3-metabolites-12-01205"><title>2.3. Sample Preparation for Flow Cytometry</title><p>Immunophenotyping was performed on blood or single-cell suspensions that were previously obtained from bone marrow centrifugation (as described in Fan Y. et al. [<xref rid="B18-metabolites-12-01205" ref-type="bibr">18</xref>]), visceral adipose tissue collagenase digestion (as previously described [<xref rid="B19-metabolites-12-01205" ref-type="bibr">19</xref>]), or liver dissociation and stratification. Whole blood was incubated with an antibody mix for 30 min at 4 &#176;C and then fixed and lysed (eBioscience, San Diego, CA, USA) following the manufacturer&#8217;s instructions. Cell suspensions from each tissue were stained with the antibody mix at 4 &#176;C for 30 min. Washes and the final resuspension for acquisition were performed using PBS with FBS 2% and EDTA 2 mM. Samples were acquired with LSRFortessa X-20 (BD) and analyzed with Novoexpress software (version 1.6.0, Agilent, Santa Clara, CA, USA). Further details on tissue preparation are provided in the <xref rid="app1-metabolites-12-01205" ref-type="app">Supplementary Materials</xref>. The antibodies used are listed in <xref rid="app1-metabolites-12-01205" ref-type="app">Supplementary Table S1</xref>.</p></sec><sec id="sec2dot4-metabolites-12-01205"><title>2.4. Femurs, Liver, and Adipose Tissues Histology</title><p>Mouse femurs were fixed in 4% paraformaldehyde for 4 h at 4 &#176;C, decalcified in 0.5 M EDTA pH 8 for 5 days at 4 &#176;C, and frozen in liquid nitrogen-cooled isopentane. Longitudinal femur sections (10 &#956;m thick) were incubated with anti-perilipin 1 antibody (1:200; Cat. No. 9349, Cell Signalling Technology&#174;, Danvers, MA, USA). An anti-rabbit secondary antibody (Jackson ImmunoResearch, West Grove, PA, USA) diluted to 1:200 in PBS plus 1% BSA was incubated for 40 min at 37 &#176;C. Nuclei were counterstained with Hoechst 33342 (Merck KGaA, Darmstadt, Germany). Images (10&#215;) were acquired with a Leica DM6B automated upright microscope (Leica Biosystems S.r.l., Milan, Italy) and then processed with Fiji/ImageJ software (version 1.50, NIH, Bethesda, MD, USA). Adipocytes were manually quantified with Fiji/ImageJ based on perilipin-1 immunostaining. </p><p>Part of the liver, VAT, SCAT, and BAT was fixed overnight in 4% buffer formalin (Sigma-Aldrich, St. Louis, MO, USA) embedded in paraffin and then 5 &#181;m tissue sections were stained with haematoxylin and eosin (H&amp;E) (Sigma-Aldrich). Images of H&amp;E-stained sections were acquired using the Axiovision Zeiss software (version 4.8, Carl Zeiss, Oberkochen, Germany) at 10&#215; magnification. We evaluated liver steatosis using ImageJ software and the adipocytes area of VAT and SCAT using the Adiposoft Plugin, considering two fields per section, for a total of 10 sections per animal. To assess hepatic neutrophil activation, immunohistochemistry staining of liver sections was performed using the Anti-Neutrophil Elastase antibody (1:200; Cat. No. ab68672, Abcam, Cambridge, UK) followed by the HRP-conjugated anti-rabbit antibody (1:750; Sigma-Aldrich), a reaction with DAB Liquid Substrate System (Sigma-Aldrich), and nuclei counterstaining with haematoxylin (Sigma-Aldrich). Images were acquired with Axiovision Zeiss software at 10x magnification and elastase-positive areas were quantified with ImageJ software.</p></sec><sec id="sec2dot5-metabolites-12-01205"><title>2.5. Proteomics Analysis</title><p>A proteomics analysis was performed as previously described [<xref rid="B20-metabolites-12-01205" ref-type="bibr">20</xref>]. Briefly, mice livers (<italic toggle="yes">n</italic> = 3 WT mice and <italic toggle="yes">n</italic> = 3 <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup>) were pooled up to 20 mg and lysed with urea 8M, Tris-HCl 0.1 M pH 8.5 in the presence of protease inhibitors at a ratio of 1:100 (Cell Signalling, Cat. No. 5872S). The liver samples were then quantified and prepared for LC-MS/MS analysis. For plasma, 30 &#956;L samples (<italic toggle="yes">n</italic> = 4 WT mice and <italic toggle="yes">n</italic> = 4 <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice) were pooled, and the concentration was quantified by NanoDrop A280 nm (Thermo Fisher Scientific, Waltham, MA, USA) for LC-MS/MS analysis. Methodological details are provided in the <xref rid="app1-metabolites-12-01205" ref-type="app">Supplementary Materials</xref>.</p></sec><sec id="sec2dot6-metabolites-12-01205"><title>2.6. Quantitative Real-Time PCR (qRT-PCR)</title><p>For the gene expression analysis, brown adipose tissue was homogenized with TissueRuptor II (Qiagen, Hilden, Germany), and total RNA was extracted using the RNeasy Lipid Tissue Kit (Qiagen) following the manufacturer&#8217;s instructions. RNA was first quantified with a NanoDrop 1000 Spectrophotometer (Thermo Fisher Scientific) and then retro-transcribed to cDNA with iScript&#8482; Reverse Transcription Supermix (Cat. No. 1708841, Bio-Rad, Hercules, CA, USA). A 20 ng sample of the cDNA was used for amplification by real-time quantitative PCR (CFX Connect Real-Time PCR Detection System instrument, Cat. No. 1855201, Bio-Rad) with the Luna<sup>&#174;</sup> Universal qPCR Master Mix (Cat. No. M3003E, New England Biolabs, Ipswich, MA, USA). For each amplification, 1 &#181;M of each primer was used to a final volume of 15 &#181;L of the reaction mix with 7.5 &#181;L of the master MIX. </p><p>The threshold cycle number (Ct) values for each reaction were calculated. Gene expression was calculated as 2<sup>&#916;&#916;Ct</sup> adjusted to the expression of the housekeeping gene <italic toggle="yes">Rpl-13a</italic> and as a fold difference of <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> to control group. The primer sequences used in this study are listed in <xref rid="app1-metabolites-12-01205" ref-type="app">Supplementary Table S2</xref>.</p></sec><sec id="sec2dot7-metabolites-12-01205"><title>2.7. Statistical Analysis</title><p>GraphPad Prism (version 9, GraphPad Software, San Diego, CA, USA) was used for graphical representation and statistical analyses of the data. Results are given as the mean per group &#177; standard error of the mean (SEM). For comparison between the two groups, an unpaired parametric two-sided T-test with a 95% confidence interval was used when the data sets followed a normal distribution. For non-normal data, the Mann&#8211;Whitney nonparametric unpaired T-test was applied. A <italic toggle="yes">p</italic>-value of &lt;0.05 was considered significant.</p><p>The DAVID (The Database for Annotation, Visualization, and Integrated Discovery, NIAID, North Bethesda, MD, USA) platform was used for gene ontology (GO) and KEGG enrichment analyses. GO and KEGG were performed using our protein LFQ dataset, and results for significant terms associated with the gene set were selected based on the FDR &lt; 0.05.</p></sec></sec><sec sec-type="results" id="sec3-metabolites-12-01205"><title>3. Results</title><sec id="sec3dot1-metabolites-12-01205"><title>3.1. Mrc1 Deficiency in Mice Fed with a High-Fat Diet Affects Bone Marrow Myelopoiesis and Adiposity, Which Results in Dampened Immune-Inflammatory Response in the Circulation</title><p>To investigate whether mannose receptor deficiency affects the immune cell profile during obesity, we first characterized the circulating immune cell profile for the <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> and control WT male mice fed an HFD for 20 weeks with a focus on myeloid populations (gating strategy shown in <xref rid="app1-metabolites-12-01205" ref-type="app">Supplementary Figure S1A&#8211;F</xref>). The <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice displayed a significant reduction in neutrophils (<xref rid="metabolites-12-01205-f001" ref-type="fig">Figure 1</xref>A) and inflammatory CCR2<sup>+</sup> monocyte counts (<xref rid="metabolites-12-01205-f001" ref-type="fig">Figure 1</xref>B). Although, the total monocyte numbers were not different between the two experimental groups (<xref rid="metabolites-12-01205-f001" ref-type="fig">Figure 1</xref>C). A trend toward the reduction of circulating CD11b<sup>+</sup> myeloid cells was also observed (<xref rid="metabolites-12-01205-f001" ref-type="fig">Figure 1</xref>D), whereas the counts of eosinophils (<xref rid="metabolites-12-01205-f001" ref-type="fig">Figure 1</xref>E) and circulating adaptive immune cells, including B and T lymphocytes, were not different (<xref rid="metabolites-12-01205-f001" ref-type="fig">Figure 1</xref>F,G). We next investigated whether this profile might be the consequence of changes in the medullary compartment of <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> as compared to WT male mice following HFD feeding. To this aim, we profiled different hematopoietic precursor subsets and mature immune cells (cell subsets investigated are presented in <xref rid="app1-metabolites-12-01205" ref-type="app">Supplementary Figure S2</xref>, and the gating strategy used is presented in <xref rid="app1-metabolites-12-01205" ref-type="app">Supplementary Figure S3A&#8211;R</xref>) in the bone marrow of the different animal models.</p><p>The number of early progenitors was similar in WT and <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice, including that of long-term hematopoietic stem cells (LT-HSCs, <xref rid="metabolites-12-01205-f001" ref-type="fig">Figure 1</xref>H), short-term hematopoietic stem cells (ST-HSCs, <xref rid="metabolites-12-01205-f001" ref-type="fig">Figure 1</xref>I), multipotent progenitors (MPPs, <xref rid="metabolites-12-01205-f001" ref-type="fig">Figure 1</xref>J), common lymphoid progenitors (CLPs, <xref rid="metabolites-12-01205-f001" ref-type="fig">Figure 1</xref>K), common myeloid progenitors (CMPs, <xref rid="metabolites-12-01205-f001" ref-type="fig">Figure 1</xref>L), and granulocyte/macrophage progenitors (GMPs, <xref rid="metabolites-12-01205-f001" ref-type="fig">Figure 1</xref>M). Interestingly, the amount of more mature cells, including granulocyte progenitors (GPs, <xref rid="metabolites-12-01205-f001" ref-type="fig">Figure 1</xref>N), pre-neutrophils (PNs, <xref rid="metabolites-12-01205-f001" ref-type="fig">Figure 1</xref>O), and mature neutrophils (MNs, <xref rid="metabolites-12-01205-f001" ref-type="fig">Figure 1</xref>Q, representative plots <xref rid="metabolites-12-01205-f001" ref-type="fig">Figure 1</xref>W), were significantly reduced in mice lacking Mrc1 as compared to controls.</p><p>Macrophage/dendritic cell progenitors (MDPs; <xref rid="metabolites-12-01205-f001" ref-type="fig">Figure 1</xref>R), monocyte precursors (MOPs, <xref rid="metabolites-12-01205-f001" ref-type="fig">Figure 1</xref>S), and mature Ly6C<sup>low</sup> (<xref rid="metabolites-12-01205-f001" ref-type="fig">Figure 1</xref>T) and Ly6C<sup>high</sup> (<xref rid="metabolites-12-01205-f001" ref-type="fig">Figure 1</xref>U) monocytes were not affected. On the other hand, macrophages identified as Gr-1<sup>&#8722;</sup>CD115<sup>&#8722;</sup>F4/80<sup>+</sup>SSC<sup>low</sup> decreased in the bone marrow of Mrc1-deficient mice compared to WT mice (<xref rid="metabolites-12-01205-f001" ref-type="fig">Figure 1</xref>V,X). This last trait was commonly associated with compromised retention of hematopoietic stem cells in the niche [<xref rid="B21-metabolites-12-01205" ref-type="bibr">21</xref>], often as the consequence of altered crosstalk between the stem cell niche and adipocytes within the bone marrow during hematopoiesis [<xref rid="B22-metabolites-12-01205" ref-type="bibr">22</xref>,<xref rid="B23-metabolites-12-01205" ref-type="bibr">23</xref>]. To investigate this hypothesis, we compared the content of adipocytes in the bone marrow of <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice to control mice using Perilipin as an adipocyte marker with immunofluorescence staining (<xref rid="metabolites-12-01205-f001" ref-type="fig">Figure 1</xref>Y). Adipocyte content significantly increased in association with Mrc1 deficiency both in terms of cells per area and absolute count (<xref rid="metabolites-12-01205-f001" ref-type="fig">Figure 1</xref>Z,AA). The observation of a similar value for adipocyte cell surface area between the experimental groups (<xref rid="metabolites-12-01205-f001" ref-type="fig">Figure 1</xref>AB) suggests that an investigation of differences in bone marrow adipogenesis is required to explain the phenotype described above. Altogether, the decreased presence of macrophages, the combination of reduced levels of myeloid precursors and mature cells, and the increased adipocyte content suggest that the lack of Mrc1 could promote a medullary rewiring in mice with diet-induced obesity. This medullary rewiring is reflected in changes to the circulating immune subsets and systemic inflammatory status.</p><p>To explore this hypothesis, untargeted proteomic analysis of the plasma from the different experimental groups was performed. Out of 4306 proteins identified, 4.4% were downregulated and 3.4% were upregulated in the plasma of obese <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice compared to that of controls (<xref rid="metabolites-12-01205-f002" ref-type="fig">Figure 2</xref>A,B). The different proteomic signature associated with Mrc1 deficiency was confirmed by Principal Component Analysis (PCA, <xref rid="metabolites-12-01205-f002" ref-type="fig">Figure 2</xref>C), which showed a cluster clearly separated from that of plasma proteins from WT mice. To better characterize this phenotype, differently abundant proteins were analyzed using the KEGG database to assess enriched pathways in the plasma of <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice compared to that of WT mice (<xref rid="metabolites-12-01205-f002" ref-type="fig">Figure 2</xref>D). Interestingly, ECM-receptor interaction, leukocyte transendothelial migration, chemokine signaling pathway, and platelet activation (FDR &lt; 0.05) displayed a higher number of downregulated proteins (<xref rid="metabolites-12-01205-f002" ref-type="fig">Figure 2</xref>E,F) in the plasma from <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice. These results suggest that the lack of the mannose receptor could affect the modulation of immune cell infiltration.</p><p>Furthermore, Ingenuity Pathway Analysis confirmed the impact of Mrc1 deficiency on the modulation of the immune system function. The impact was shown by inhibited canonical pathways (Z-score based) including hepatic fibrosis signaling, NF-kB signaling, PKC&#952; signaling in T cells, necroptosis, and increased PD-1/PD-L1 pathway (<xref rid="metabolites-12-01205-f002" ref-type="fig">Figure 2</xref>G).</p><p>Overall, these data suggest that Mrc1 deficiency results in a protective BM phenotype characterized by decreased myelopoiesis and increased presence of quiescence-promoting adipocytes, coupled with changes in plasma proteome associated with a reduced number of pro-inflammatory and tissue-infiltrating leukocytes.</p></sec><sec id="sec3dot2-metabolites-12-01205"><title>3.2. Mrc1 Deficiency in Mice Fed with a High-Fat Diet Impacts Immune Infiltration of Metabolic Tissues during Obesity</title><p>We performed flow cytometry analyses on the visceral adipose tissue (VAT) and liver of WT and <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice fed with an HFD for 20 weeks to investigate whether the reduced inflammatory and migratory phenotype of myeloid cells in circulation&#8212;as suggested by proteomics analysis&#8212;was reflected by different recruitment of immune cells in metabolically affected tissues. Interestingly, the mannose receptor deficiency was associated with a significant reduction in macrophages, specifically in monocyte-derived macrophages (<xref rid="metabolites-12-01205-f003" ref-type="fig">Figure 3</xref>A&#8211;C, gating strategy shown in <xref rid="app1-metabolites-12-01205" ref-type="app">Supplementary Figure S4A&#8211;I</xref>), within VAT, which suggests a different infiltrating capacity. This reduction was paralleled by a significant decrease in inflammatory CD11c<sup>+</sup> macrophages (<xref rid="metabolites-12-01205-f003" ref-type="fig">Figure 3</xref>D,F) in the <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice compared to the controls, which was particularly evident in the subpopulation of macrophages expressing intermediate levels of F4/80 (<xref rid="metabolites-12-01205-f003" ref-type="fig">Figure 3</xref>E) that are known to originate from circulating monocytes [<xref rid="B24-metabolites-12-01205" ref-type="bibr">24</xref>]. A trend toward reduced VAT infiltrating myeloid cells, monocytes, and CD11c<sup>+</sup>F4/80<sup>high</sup> macrophages was also observed (<xref rid="metabolites-12-01205-f003" ref-type="fig">Figure 3</xref>G&#8211;J). This trend was not observed for neutrophils and eosinophils (<xref rid="metabolites-12-01205-f003" ref-type="fig">Figure 3</xref>K,L).</p><p>In parallel, liver immunophenotyping (gating strategy shown in <xref rid="app1-metabolites-12-01205" ref-type="app">Supplementary Figure S5A&#8211;H</xref>) showed decreased levels of myeloid cells (<xref rid="metabolites-12-01205-f003" ref-type="fig">Figure 3</xref>M) in <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice, which was more evident for monocytes (<xref rid="metabolites-12-01205-f003" ref-type="fig">Figure 3</xref>N,P) and monocyte-derived macrophages (<xref rid="metabolites-12-01205-f003" ref-type="fig">Figure 3</xref>O) but not for other cell subsets (<xref rid="app1-metabolites-12-01205" ref-type="app">Supplementary Figure S5I&#8211;O</xref>). Interestingly, although neutrophils were present in a comparable fashion in both experimental groups (<xref rid="app1-metabolites-12-01205" ref-type="app">Supplementary Figure S5K</xref>), histological analysis of the expression of elastase&#8212;a marker of neutrophil activation&#8212;on liver sections revealed a trend toward reduction in <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice compared to controls (<xref rid="app1-metabolites-12-01205" ref-type="app">Supplementary Figure S5P,Q</xref>). Such a reduction is in line with a less severe inflammatory phenotype associated with the lack of the mannose receptor.</p></sec><sec id="sec3dot3-metabolites-12-01205"><title>3.3. Immunomodulation in Mrc1<sup>&#8722;/&#8722;</sup> Mice Is Associated with Improved Obese Phenotype</title><p>We compared weight gain in <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> and WT mice fed a high-fat diet to evaluate whether the observed differences in the immune phenotype translate into an improved metabolic profile. This comparison revealed a significant reduction in the weight gain of <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice compared to their WT counterpart (<xref rid="metabolites-12-01205-f004" ref-type="fig">Figure 4</xref>A,B), which was in line with a recent report [<xref rid="B25-metabolites-12-01205" ref-type="bibr">25</xref>]. This difference was not the result of changes in visceral adipose tissue or subcutaneous adipose tissue. However, significant differences were observed in the relative weight of brown adipose tissue (BAT) and the liver (<xref rid="metabolites-12-01205-f004" ref-type="fig">Figure 4</xref>C). Nonetheless, the moderate impact of these differences in explaining the reduction of animal weight suggests that Mrc1 deficiency in mice fed an HFD might affect other tissues that were not evaluated in our work. This limitation should be addressed in future studies. Notably, the adipocyte area was not different in the VAT or SCAT from <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> and WT mice (<xref rid="metabolites-12-01205-f004" ref-type="fig">Figure 4</xref>D&#8211;F), but smaller lipid droplets were observed in brown adipose tissue (BAT) (<xref rid="metabolites-12-01205-f004" ref-type="fig">Figure 4</xref>D). These smaller lipid droplets were coupled to significant changes in the gene expression profile of genes associated with BAT function such as <italic toggle="yes">Ppara</italic>, <italic toggle="yes">Pgc1a</italic>, <italic toggle="yes">Atgl</italic> and <italic toggle="yes">Ucp1</italic> (<xref rid="metabolites-12-01205-f004" ref-type="fig">Figure 4</xref>G).</p><p>Reduced lipid accumulation was also observed in the liver (<xref rid="metabolites-12-01205-f004" ref-type="fig">Figure 4</xref>H, I) prompting us to profile liver proteome. Among 2114 proteins, 344 were downregulated and 363 were upregulated in <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice (<xref rid="app1-metabolites-12-01205" ref-type="app">Supplementary Figure S6A,B</xref>). Differently abundant proteins were analyzed using the KEGG database to assess enriched pathways (<xref rid="metabolites-12-01205-f004" ref-type="fig">Figure 4</xref>J), which were identified as being mainly metabolism related. One of the enriched pathways is non-alcoholic fatty liver disease, or NAFLD, in which most molecules appear less abundant in association with mannose receptor deficiency (<xref rid="metabolites-12-01205-f004" ref-type="fig">Figure 4</xref>K), thus confirming the previous histological analysis. On the other hand, the gene ontology (GO) analysis identified the enrichment of the cellular response to the IL-4 pathway, where proteins are mainly upregulated (<xref rid="metabolites-12-01205-f004" ref-type="fig">Figure 4</xref>L). This result suggests the presence of pro-resolutive immune activation, which aligns with an overall downregulation of proteins within the cellular response to the IFN-&#436; pathway [<xref rid="B26-metabolites-12-01205" ref-type="bibr">26</xref>] and with the reduced infiltration observed by flow cytometry. Reduced steatosis and inflammation pair with improved glucose and insulin tolerance, as shown by more upregulated proteins in the GO cellular response to the insulin stimulus pathway (<xref rid="metabolites-12-01205-f004" ref-type="fig">Figure 4</xref>L), as well as a better performance following the glucose tolerance test (GTT, <xref rid="metabolites-12-01205-f004" ref-type="fig">Figure 4</xref>M) and an improved trend following insulin tolerance test (ITT, <xref rid="metabolites-12-01205-f004" ref-type="fig">Figure 4</xref>N). However, no significant changes were observed in plasma triglyceride and cholesterol levels (<xref rid="app1-metabolites-12-01205" ref-type="app">Supplementary Figure S6C,D</xref>). Thus, we observed that in mice fed an HFD for 20 weeks, the absence of the mannose receptor leads to a protective BM phenotype and a reduced leukocyte infiltration tendency, which associates with overall protection from obesity-related dysfunctions.</p></sec></sec><sec sec-type="discussion" id="sec4-metabolites-12-01205"><title>4. Discussion</title><p>Metabolic diseases, such as type 2 diabetes mellitus, are associated with increased hematopoiesis [<xref rid="B27-metabolites-12-01205" ref-type="bibr">27</xref>] and dysfunctional endothelium, which in turn contribute to disrupting myelopoiesis [<xref rid="B17-metabolites-12-01205" ref-type="bibr">17</xref>]. This pro-inflammatory hematopoiesis not only aggravates the dysmetabolic condition but also stands as an important risk factor for cardiovascular diseases [<xref rid="B28-metabolites-12-01205" ref-type="bibr">28</xref>], calling for an investigation of the molecular mechanisms driving this effect. Intriguingly, the soluble mannose receptor has been shown to stimulate tissue macrophage activation towards inflammation, and its deficiency in mice fed an HFD resulted in reduced tissue inflammation and a better metabolic phenotype [<xref rid="B25-metabolites-12-01205" ref-type="bibr">25</xref>].</p><p>However, the use of a whole-body <italic toggle="yes">Mrc1</italic> knock-out mouse model has suggested that the wide range in the expression of this receptor [<xref rid="B10-metabolites-12-01205" ref-type="bibr">10</xref>] would account for additional activities. In this context, we showed that Mrc1 deficiency results in reduced inflammation that might be the consequence of important changes in bone marrow cell signature. </p><p>Interestingly, Mrc1 is expressed by both macrophages and medullary sinusoidal endothelial cells [<xref rid="B14-metabolites-12-01205" ref-type="bibr">14</xref>], where its expression increases following the onset of diabetes mellitus within a panel of inflammatory genes [<xref rid="B17-metabolites-12-01205" ref-type="bibr">17</xref>]. Highly active myelopoiesis observed in dysmetabolic conditions is commonly associated with a systemic immune activation characterized by the increased frequency of blood inflammatory cells and circulating markers of inflammation [<xref rid="B29-metabolites-12-01205" ref-type="bibr">29</xref>]. In our experimental setting, decreased levels of circulating neutrophils and pro-inflammatory CCR2<sup>+</sup> monocytes were indeed associated with the bone marrow phenotype switch in Mrc1-deficient mice. Our work revealed that the lack of the mannose receptor modulates myelopoiesis, thus hampering the enhancement observed in animals fed with an HFD to induce obesity [<xref rid="B30-metabolites-12-01205" ref-type="bibr">30</xref>]. We demonstrated an important downregulation of myeloid cell production as well as an increased presence of adipocytes. Considering the role of CXCL12 in promoting HSCs quiescence, an increase in adipocytes, a known source of CXCL12, could negatively modulate hematopoiesis by reducing the production of inflammatory cells [<xref rid="B22-metabolites-12-01205" ref-type="bibr">22</xref>]. As a confirmation, our plasma proteomics analysis showed that the lack of the mannose receptor is paralleled by an overall reduction in leukocyte migration and the tissue infiltration pathways. Notably, changes in glycoprotein catabolism play a critical role in lipoprotein metabolism and cardiometabolic diseases [<xref rid="B31-metabolites-12-01205" ref-type="bibr">31</xref>].</p><p>Therefore, we investigated the immune phenotype of the visceral adipose tissue and liver, as they represent tissues at the crossroad between the metabolic and inflammatory response to obesity [<xref rid="B32-metabolites-12-01205" ref-type="bibr">32</xref>,<xref rid="B33-metabolites-12-01205" ref-type="bibr">33</xref>]. In Mrc1-deficient mice, both tissues presented a reduced infiltration of myeloid cells that contributed to an amelioration of the metabolic response during HFD. Indeed, the recruitment of monocytes from circulation to adipose tissue promotes the differentiation of macrophages with a pro-inflammatory phenotype at the cost of anti-inflammatory macrophages [<xref rid="B34-metabolites-12-01205" ref-type="bibr">34</xref>].</p><p>Notably, Mrc1 deficiency appears to counterbalance this effect, limiting the immunometabolic response observed during obesity. This finding seems unexpected given that the Mrc1 receptor is one of the key markers of pro-resolutive macrophages [<xref rid="B35-metabolites-12-01205" ref-type="bibr">35</xref>]. However, previous studies have shown that the selective depletion of Mrc1<sup>+</sup> macrophages improves the systemic insulin response and lipid handling in adipose tissue [<xref rid="B36-metabolites-12-01205" ref-type="bibr">36</xref>]. These results suggest the presence of parallel mechanisms related to the presence of the mannose receptor that might be associated with the progression of metabolic disorders.</p><p>Of note, in this study, we used whole-body <italic toggle="yes">Mrc1</italic> knock-out mice. Therefore, it is possible that cells other than macrophages contributed to the phenotype observed. Indeed, in addition to macrophages, the mannose receptor is expressed by a variety of cells including non-immune cells, such as sinusoidal endothelial cells [<xref rid="B1-metabolites-12-01205" ref-type="bibr">1</xref>]. These cells have been implicated in leucocyte trafficking in lymphatic vessels [<xref rid="B9-metabolites-12-01205" ref-type="bibr">9</xref>]. Therefore, future studies should investigate whether leucocyte trafficking could also play a role in the observed phenotype.</p><p>In conclusion, we have shown that, during the onset of obesity, Mrc1 impacts hematopoietic stem cell differentiation and release. In addition, Mrc1 deficiency impacts the BM cell profile and reduces the number of activated immune cells in circulation and their infiltration in tissues, thus dampening obesity development.</p></sec></body><back><ack><title>Acknowledgments</title><p>We thank the Genotoul Anexplo-IPBS platform (Toulouse) for help with animal husbandry. The hematopoiesis diagram in <xref rid="app1-metabolites-12-01205" ref-type="app">Supplementary Figure S2</xref> was generated by using pictures from Servier Medical Art, provided by Servier, licensed under a Creative Commons Attribution 3.0 unported license.</p></ack><fn-group><fn><p><bold>Publisher&#8217;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><app-group><app id="app1-metabolites-12-01205"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.mdpi.com/article/10.3390/metabo12121205/s1">https://www.mdpi.com/article/10.3390/metabo12121205/s1</uri>; Further description of tissue preparation for flow cytometry and proteomics analyses; Figure S1: Blood flow cytometry gating strategy for immunophenotyping of WT and <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice on a high-fat diet; Figure S2: Hematopoiesis diagram; Figure S3: Gating strategy for bone marrow immunophenotyping [<xref rid="B37-metabolites-12-01205" ref-type="bibr">37</xref>]; Figure S4: Visceral adipose tissue flow cytometry gating strategy for immunophenotyping of WT and <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice with diet-induced obesity; Figure S5: Liver flow cytometry gating strategy and liver immune characterization of WT and <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice fed with HFD; Figure S6: Impact of Mrc1 deficiency on the metabolic phenotype in mice with diet-induced obesity; Table S1: Antibodies used for flow cytometry analyses; Table S2: Primer sequences used for real time qPCR on BAT samples.</p><supplementary-material id="metabolites-12-01205-s001" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="metabolites-12-01205-s001.zip" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceived and designed the experiments, J.N., F.B. and G.D.N.; performed the experiments, J.N., A.M., M.S., R.B., M.A. and F.B; analyzed the data, J.N., M.S., L.D.D. and F.B; wrote the paper: J.N., F.B. and G.D.N.; revised the manuscript, F.B., G.D.N., A.M., M.A., O.N., G.P.F. and Y.R. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>The animal study protocol was approved by Ethical Committee (Progetto di Ricerca 2012/02, Autorizzazione Ministeriale 929/2020) and conformed the guidelines from directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The data presented in this study are openly available in FigShare at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.6084/m9.figshare.21623523.v1">https://doi.org/10.6084/m9.figshare.21623523.v1</uri> [<xref rid="B38-metabolites-12-01205" ref-type="bibr">38</xref>].</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-metabolites-12-01205"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elvevold</surname><given-names>K.</given-names></name><name name-style="western"><surname>Simon-Santamaria</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hasvold</surname><given-names>H.</given-names></name><name name-style="western"><surname>McCourt</surname><given-names>P.</given-names></name><name name-style="western"><surname>Smedsr&#248;d</surname><given-names>B.</given-names></name><name name-style="western"><surname>S&#248;rensen</surname><given-names>K.K.</given-names></name></person-group><article-title>Liver Sinusoidal Endothelial Cells Depend on Mannose Receptor-Mediated Recruitment of Lysosomal Enzymes for Normal Degradation Capacity</article-title><source>Hepatology</source><year>2008</year><volume>48</volume><fpage>2007</fpage><lpage>2015</lpage><pub-id pub-id-type="doi">10.1002/hep.22527</pub-id><pub-id pub-id-type="pmid">19026003</pub-id></element-citation></ref><ref id="B2-metabolites-12-01205"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McKenzie</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>P.R.</given-names></name><name name-style="western"><surname>Stillion</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Lucas</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Harris</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>S.</given-names></name><name name-style="western"><surname>Martinez-Pomares</surname><given-names>L.</given-names></name></person-group><article-title>Mannose Receptor Expression and Function Define a New Population of Murine Dendritic Cells</article-title><source>J. Immunol.</source><year>2007</year><volume>178</volume><fpage>4975</fpage><lpage>4983</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.178.8.4975</pub-id><pub-id pub-id-type="pmid">17404279</pub-id></element-citation></ref><ref id="B3-metabolites-12-01205"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>R&#248;dgaard-Hansen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rafique</surname><given-names>A.</given-names></name><name name-style="western"><surname>Christensen</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Maniecki</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Sandahl</surname><given-names>T.D.</given-names></name><name name-style="western"><surname>Nex&#248;</surname><given-names>E.</given-names></name><name name-style="western"><surname>M&#248;ller</surname><given-names>H.J.</given-names></name></person-group><article-title>A soluble form of the macrophage-related mannose receptor (MR/CD206) is present in human serum and elevated in critical illness</article-title><source>Clin. Chem. Lab. Med.</source><year>2014</year><volume>52</volume><fpage>453</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1515/cclm-2013-0451</pub-id><pub-id pub-id-type="pmid">24114918</pub-id></element-citation></ref><ref id="B4-metabolites-12-01205"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mullin</surname><given-names>N.P.</given-names></name><name name-style="western"><surname>Hall</surname><given-names>K.T.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>M.E.</given-names></name></person-group><article-title>Characterization of ligand binding to a carbohydrate-recognition domain of the macrophage mannose receptor</article-title><source>J. Biol. Chem.</source><year>1994</year><volume>269</volume><fpage>28405</fpage><lpage>28413</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(18)46942-6</pub-id><pub-id pub-id-type="pmid">7961781</pub-id></element-citation></ref><ref id="B5-metabolites-12-01205"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martinez-Pomares</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wienke</surname><given-names>D.</given-names></name><name name-style="western"><surname>Stillion</surname><given-names>R.</given-names></name><name name-style="western"><surname>McKenzie</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Arnold</surname><given-names>J.</given-names></name><name name-style="western"><surname>Harris</surname><given-names>J.</given-names></name><name name-style="western"><surname>McGreal</surname><given-names>E.</given-names></name><name name-style="western"><surname>Sim</surname><given-names>R.</given-names></name><name name-style="western"><surname>Isacke</surname><given-names>C.</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>S.</given-names></name></person-group><article-title>Carbohydrate-independent recognition of collagens by the macrophage mannose receptor</article-title><source>Eur. J. Immunol.</source><year>2006</year><volume>36</volume><fpage>1074</fpage><lpage>1082</lpage><pub-id pub-id-type="doi">10.1002/eji.200535685</pub-id><pub-id pub-id-type="pmid">16619293</pub-id></element-citation></ref><ref id="B6-metabolites-12-01205"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chirino</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Misulovin</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Leteux</surname><given-names>C.</given-names></name><name name-style="western"><surname>Feizi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Nussenzweig</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Bjorkman</surname><given-names>P.J.</given-names></name></person-group><article-title>Crystal structure of the cysteine-rich domain of mannose receptor complexed with a sulfated carbohydrate ligand</article-title><source>J. Exp. Med.</source><year>2000</year><volume>191</volume><fpage>1105</fpage><lpage>1115</lpage><pub-id pub-id-type="doi">10.1084/jem.191.7.1105</pub-id><pub-id pub-id-type="pmid">10748229</pub-id><pub-id pub-id-type="pmcid">PMC2193177</pub-id></element-citation></ref><ref id="B7-metabolites-12-01205"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Shapiro</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Baenziger</surname><given-names>J.U.</given-names></name></person-group><article-title>Regulation of lutropin circulatory half-life by the mannose/N-acetylgalactosamine-4-SO<sub>4</sub> receptor is critical for implantation in vivo</article-title><source>J. Clin. Investig.</source><year>2002</year><volume>109</volume><fpage>269</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1172/JCI13997</pub-id><pub-id pub-id-type="pmid">11805139</pub-id><pub-id pub-id-type="pmcid">PMC150840</pub-id></element-citation></ref><ref id="B8-metabolites-12-01205"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Coonce</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fiete</surname><given-names>D.</given-names></name><name name-style="western"><surname>Steirer</surname><given-names>L.</given-names></name><name name-style="western"><surname>Dveksler</surname><given-names>G.</given-names></name><name name-style="western"><surname>Townsend</surname><given-names>R.R.</given-names></name><name name-style="western"><surname>Baenziger</surname><given-names>J.U.</given-names></name></person-group><article-title>Functional consequences of mannose and asialoglycoprotein receptor ablation</article-title><source>J. Biol. Chem.</source><year>2016</year><volume>291</volume><fpage>18700</fpage><lpage>18717</lpage><pub-id pub-id-type="doi">10.1074/jbc.M116.738948</pub-id><pub-id pub-id-type="pmid">27405760</pub-id><pub-id pub-id-type="pmcid">PMC5009246</pub-id></element-citation></ref><ref id="B9-metabolites-12-01205"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salmi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Karikoski</surname><given-names>M.</given-names></name><name name-style="western"><surname>Elima</surname><given-names>K.</given-names></name><name name-style="western"><surname>Rantakari</surname><given-names>P.</given-names></name><name name-style="western"><surname>Jalkanen</surname><given-names>S.</given-names></name></person-group><article-title>CD44 Binds to Macrophage Mannose Receptor on Lymphatic Endothelium and Supports Lymphocyte Migration via Afferent Lymphatics</article-title><source>Circ. Res.</source><year>2013</year><volume>112</volume><fpage>1577</fpage><lpage>1582</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.300476</pub-id><pub-id pub-id-type="pmid">23603511</pub-id></element-citation></ref><ref id="B10-metabolites-12-01205"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martinez-Pomares</surname><given-names>L.</given-names></name></person-group><article-title>The mannose receptor</article-title><source>J. Leukoc. Biol.</source><year>2012</year><volume>92</volume><fpage>1177</fpage><lpage>1186</lpage><pub-id pub-id-type="doi">10.1189/jlb.0512231</pub-id><pub-id pub-id-type="pmid">22966131</pub-id></element-citation></ref><ref id="B11-metabolites-12-01205"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Evers</surname><given-names>S.</given-names></name><name name-style="western"><surname>Roeder</surname><given-names>D.</given-names></name><name name-style="western"><surname>Parlow</surname><given-names>A.F.</given-names></name><name name-style="western"><surname>Risteli</surname><given-names>J.</given-names></name><name name-style="western"><surname>Risteli</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y.C.</given-names></name><name name-style="western"><surname>Feizi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Langen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Nussenzweig</surname><given-names>M.C.</given-names></name></person-group><article-title>Mannose receptor-mediated regulation of serum glycoprotein homeostasis</article-title><source>Science</source><year>2002</year><volume>295</volume><fpage>1898</fpage><lpage>1901</lpage><pub-id pub-id-type="doi">10.1126/science.1069540</pub-id><pub-id pub-id-type="pmid">11884756</pub-id></element-citation></ref><ref id="B12-metabolites-12-01205"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gazi</surname><given-names>U.</given-names></name><name name-style="western"><surname>Martinez-Pomares</surname><given-names>L.</given-names></name></person-group><article-title>Influence of the mannose receptor in host immune responses</article-title><source>Immunobiology</source><year>2009</year><volume>214</volume><fpage>554</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1016/j.imbio.2008.11.004</pub-id><pub-id pub-id-type="pmid">19162368</pub-id></element-citation></ref><ref id="B13-metabolites-12-01205"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heideveld</surname><given-names>E.</given-names></name><name name-style="western"><surname>van den Akker</surname><given-names>E.</given-names></name></person-group><article-title>Digesting the role of bone marrow macrophages on hematopoiesis</article-title><source>Immunobiology</source><year>2017</year><volume>222</volume><fpage>814</fpage><lpage>822</lpage><pub-id pub-id-type="doi">10.1016/j.imbio.2016.11.007</pub-id><pub-id pub-id-type="pmid">27890297</pub-id></element-citation></ref><ref id="B14-metabolites-12-01205"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Helbling</surname><given-names>P.M.</given-names></name><name name-style="western"><surname>Pi&#241;eiro-Yanez</surname><given-names>E.</given-names></name><name name-style="western"><surname>Gerosa</surname><given-names>R.</given-names></name><name name-style="western"><surname>Boettcher</surname><given-names>S.</given-names></name><name name-style="western"><surname>Al-Shahrour</surname><given-names>F.</given-names></name><name name-style="western"><surname>Manz</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Nombela-Arrieta</surname><given-names>C.</given-names></name></person-group><article-title>Global Transcriptomic Profiling of the Bone Marrow Stromal Microenvironment during Postnatal Resource Global Transcriptomic Profiling of the Bone Marrow Stromal Microenvironment during Postnatal Development, Aging, and Inflammation</article-title><source>Cell Rep.</source><year>2019</year><volume>29</volume><fpage>3313</fpage><lpage>3330</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.11.004</pub-id><pub-id pub-id-type="pmid">31801092</pub-id></element-citation></ref><ref id="B15-metabolites-12-01205"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ashok</surname><given-names>D.</given-names></name><name name-style="western"><surname>Polcik</surname><given-names>L.</given-names></name><name name-style="western"><surname>Prosseda</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Hartmann</surname><given-names>T.N.</given-names></name></person-group><article-title>Insights into Bone Marrow Niche Stability: An Adhesion and Metabolism Route</article-title><source>Front. Cell Dev. Biol.</source><year>2022</year><volume>9</volume><fpage>798604</fpage><pub-id pub-id-type="doi">10.3389/fcell.2021.798604</pub-id><pub-id pub-id-type="pmid">35118078</pub-id><pub-id pub-id-type="pmcid">PMC8806031</pub-id></element-citation></ref><ref id="B16-metabolites-12-01205"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Norata</surname><given-names>G.D.</given-names></name><name name-style="western"><surname>Caligiuri</surname><given-names>G.</given-names></name><name name-style="western"><surname>Chavakis</surname><given-names>T.</given-names></name><name name-style="western"><surname>Matarese</surname><given-names>G.</given-names></name><name name-style="western"><surname>Netea</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Nicoletti</surname><given-names>A.</given-names></name><name name-style="western"><surname>O&#8217;Neill</surname><given-names>L.A.J.</given-names></name><name name-style="western"><surname>Marelli-Berg</surname><given-names>F.M.</given-names></name></person-group><article-title>The Cellular and Molecular Basis of Translational Immunometabolism</article-title><source>Immunity</source><year>2015</year><volume>43</volume><fpage>421</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2015.08.023</pub-id><pub-id pub-id-type="pmid">26377896</pub-id></element-citation></ref><ref id="B17-metabolites-12-01205"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoyer</surname><given-names>F.F.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Coppin</surname><given-names>E.</given-names></name><name name-style="western"><surname>Vasamsetti</surname><given-names>S.B.</given-names></name><name name-style="western"><surname>Modugu</surname><given-names>G.</given-names></name><name name-style="western"><surname>Schloss</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Rohde</surname><given-names>D.</given-names></name><name name-style="western"><surname>McAlpine</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Iwamoto</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Libby</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Bone marrow endothelial cells regulate myelopoiesis in diabetes mellitus</article-title><source>Circulation</source><year>2020</year><volume>142</volume><fpage>244</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.120.046038</pub-id><pub-id pub-id-type="pmid">32316750</pub-id><pub-id pub-id-type="pmcid">PMC7375017</pub-id></element-citation></ref><ref id="B18-metabolites-12-01205"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hanai</surname><given-names>J.-I.</given-names></name><name name-style="western"><surname>Le</surname><given-names>P.T.</given-names></name><name name-style="western"><surname>Bi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Maridas</surname><given-names>D.</given-names></name><name name-style="western"><surname>DeMambro</surname><given-names>V.</given-names></name><name name-style="western"><surname>Figueroa</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Kir</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X.</given-names></name><name name-style="western"><surname>Mannstadt</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Parathyroid Hormone Directs Bone Marrow Mesenchymal Cell Fate</article-title><source>Cell Metab.</source><year>2017</year><volume>25</volume><fpage>661</fpage><lpage>672</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2017.01.001</pub-id><pub-id pub-id-type="pmid">28162969</pub-id><pub-id pub-id-type="pmcid">PMC5342925</pub-id></element-citation></ref><ref id="B19-metabolites-12-01205"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bonacina</surname><given-names>F.</given-names></name><name name-style="western"><surname>Moregola</surname><given-names>A.</given-names></name><name name-style="western"><surname>Porte</surname><given-names>R.</given-names></name><name name-style="western"><surname>Baragetti</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bonavita</surname><given-names>E.</given-names></name><name name-style="western"><surname>Salatin</surname><given-names>A.</given-names></name><name name-style="western"><surname>Grigore</surname><given-names>L.</given-names></name><name name-style="western"><surname>Pellegatta</surname><given-names>F.</given-names></name><name name-style="western"><surname>Molgora</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sironi</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Pentraxin 3 deficiency protects from the metabolic inflammation associated to diet-induced obesity</article-title><source>Cardiovasc. Res.</source><year>2019</year><volume>115</volume><fpage>1861</fpage><lpage>1872</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvz068</pub-id><pub-id pub-id-type="pmid">30859179</pub-id></element-citation></ref><ref id="B20-metabolites-12-01205"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Svecla</surname><given-names>M.</given-names></name><name name-style="western"><surname>Garrone</surname><given-names>G.</given-names></name><name name-style="western"><surname>Far&#233;</surname><given-names>F.</given-names></name><name name-style="western"><surname>Aletti</surname><given-names>G.</given-names></name><name name-style="western"><surname>Norata</surname><given-names>G.D.</given-names></name><name name-style="western"><surname>Beretta</surname><given-names>G.</given-names></name></person-group><article-title>DDASSQ: An open-source, multiple peptide sequencing strategy for label free quantification based on an OpenMS pipeline in the KNIME analytics platform</article-title><source>Proteomics</source><year>2021</year><volume>21</volume><fpage>e2000319</fpage><pub-id pub-id-type="doi">10.1002/pmic.202000319</pub-id><pub-id pub-id-type="pmid">34312990</pub-id><pub-id pub-id-type="pmcid">PMC8459258</pub-id></element-citation></ref><ref id="B21-metabolites-12-01205"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chow</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lucas</surname><given-names>D.</given-names></name><name name-style="western"><surname>Hidalgo</surname><given-names>A.</given-names></name><name name-style="western"><surname>M&#233;ndez-Ferrer</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hashimoto</surname><given-names>D.</given-names></name><name name-style="western"><surname>Scheiermann</surname><given-names>C.</given-names></name><name name-style="western"><surname>Battista</surname><given-names>M.</given-names></name><name name-style="western"><surname>Leboeuf</surname><given-names>M.</given-names></name><name name-style="western"><surname>Prophete</surname><given-names>C.</given-names></name><name name-style="western"><surname>van Rooijen</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche</article-title><source>J. Exp. Med.</source><year>2011</year><volume>208</volume><fpage>761</fpage><lpage>771</lpage><pub-id pub-id-type="doi">10.1084/jem.20101688</pub-id><pub-id pub-id-type="pmid">21282381</pub-id><pub-id pub-id-type="pmcid">PMC3039855</pub-id></element-citation></ref><ref id="B22-metabolites-12-01205"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naveiras</surname><given-names>O.</given-names></name><name name-style="western"><surname>Nardi</surname><given-names>V.</given-names></name><name name-style="western"><surname>Wenzel</surname><given-names>P.L.</given-names></name><name name-style="western"><surname>Hauschka</surname><given-names>P.V.</given-names></name><name name-style="western"><surname>Fahey</surname><given-names>F.</given-names></name><name name-style="western"><surname>Daley</surname><given-names>G.Q.</given-names></name></person-group><article-title>Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment</article-title><source>Nature</source><year>2009</year><volume>460</volume><fpage>259</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1038/nature08099</pub-id><pub-id pub-id-type="pmid">19516257</pub-id><pub-id pub-id-type="pmcid">PMC2831539</pub-id></element-citation></ref><ref id="B23-metabolites-12-01205"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>B.O.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yue</surname><given-names>R.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Rios</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Naveiras</surname><given-names>O.</given-names></name><name name-style="western"><surname>Morrison</surname><given-names>S.J.</given-names></name></person-group><article-title>Bone marrow adipocytes promote the regeneration of stem cells and haematopoiesis by secreting SCF</article-title><source>Nat. Cell Biol.</source><year>2017</year><volume>19</volume><fpage>891</fpage><lpage>903</lpage><pub-id pub-id-type="doi">10.1038/ncb3570</pub-id><pub-id pub-id-type="pmid">28714970</pub-id><pub-id pub-id-type="pmcid">PMC5536858</pub-id></element-citation></ref><ref id="B24-metabolites-12-01205"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>Y.-S.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>M.-H.</given-names></name><name name-style="western"><surname>Yi</surname><given-names>H.-S.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H.-H.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Yeon</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Byun</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Byun</surname><given-names>J.-S.</given-names></name><name name-style="western"><surname>Jeong</surname><given-names>W.I.</given-names></name></person-group><article-title>CX<sub>3</sub>CR1 differentiates F4/80<sup>low</sup> monocytes into pro-inflammatory F4/80<sup>high</sup> macrophages in the liver</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><fpage>15076</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-33440-9</pub-id><pub-id pub-id-type="pmid">30305672</pub-id><pub-id pub-id-type="pmcid">PMC6180058</pub-id></element-citation></ref><ref id="B25-metabolites-12-01205"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Embgenbroich</surname><given-names>M.</given-names></name><name name-style="western"><surname>van der Zande</surname><given-names>H.J.P.</given-names></name><name name-style="western"><surname>Hussaarts</surname><given-names>L.</given-names></name><name name-style="western"><surname>Schulte-Schrepping</surname><given-names>J.</given-names></name><name name-style="western"><surname>Pelgrom</surname><given-names>L.R.</given-names></name><name name-style="western"><surname>Garc&#237;a-Tard&#243;n</surname><given-names>N.</given-names></name><name name-style="western"><surname>Schlautmann</surname><given-names>L.</given-names></name><name name-style="western"><surname>Stoetzel</surname><given-names>I.</given-names></name><name name-style="western"><surname>H&#228;ndler</surname><given-names>K.</given-names></name><name name-style="western"><surname>Lambooij</surname><given-names>J.M.</given-names></name><etal/></person-group><article-title>Soluble mannose receptor induces proinflammatory macrophage activation and metaflammation</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2021</year><volume>118</volume><fpage>e2103304118</fpage><pub-id pub-id-type="doi">10.1073/pnas.2103304118</pub-id><pub-id pub-id-type="pmid">34326259</pub-id><pub-id pub-id-type="pmcid">PMC8346872</pub-id></element-citation></ref><ref id="B26-metabolites-12-01205"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>X.Y.</given-names></name><name name-style="western"><surname>Takahara</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kawai</surname><given-names>K.</given-names></name><name name-style="western"><surname>Fujino</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sugiyama</surname><given-names>T.</given-names></name><name name-style="western"><surname>Tsuneyama</surname><given-names>K.</given-names></name><name name-style="western"><surname>Tsukada</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nakae</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>L.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.K.</given-names></name></person-group><article-title>IFN-&#947; deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet</article-title><source>Am. J. Physiol. Gastrointest. Liver Physiol.</source><year>2013</year><volume>305</volume><fpage>891</fpage><lpage>899</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.00193.2013</pub-id><pub-id pub-id-type="pmid">24136786</pub-id></element-citation></ref><ref id="B27-metabolites-12-01205"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Albiero</surname><given-names>M.</given-names></name><name name-style="western"><surname>Poncina</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ciciliot</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cappellari</surname><given-names>R.</given-names></name><name name-style="western"><surname>Menegazzo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ferraro</surname><given-names>F.</given-names></name><name name-style="western"><surname>Bolego</surname><given-names>C.</given-names></name><name name-style="western"><surname>Cignarella</surname><given-names>A.</given-names></name><name name-style="western"><surname>Avogaro</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fadini</surname><given-names>G.P.</given-names></name></person-group><article-title>Bone marrow macrophages contribute to diabetic stem cell mobilopathy by producing oncostatin M</article-title><source>Diabetes</source><year>2015</year><volume>64</volume><fpage>2957</fpage><lpage>2968</lpage><pub-id pub-id-type="doi">10.2337/db14-1473</pub-id><pub-id pub-id-type="pmid">25804939</pub-id></element-citation></ref><ref id="B28-metabolites-12-01205"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baragetti</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bonacina</surname><given-names>F.</given-names></name><name name-style="western"><surname>Catapano</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Norata</surname><given-names>G.D.</given-names></name></person-group><article-title>Effect of Lipids and Lipoproteins on Hematopoietic Cell Metabolism and Commitment in Atherosclerosis</article-title><source>Immunometabolism</source><year>2021</year><volume>3</volume><fpage>e210014</fpage><pub-id pub-id-type="doi">10.20900/immunometab20210014</pub-id><pub-id pub-id-type="pmid">33859831</pub-id><pub-id pub-id-type="pmcid">PMC7610604</pub-id></element-citation></ref><ref id="B29-metabolites-12-01205"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bowers</surname><given-names>E.</given-names></name><name name-style="western"><surname>Singer</surname><given-names>K.</given-names></name></person-group><article-title>Obesity-induced inflammation: The impact of the hematopoietic stem cell niche</article-title><source>JCI Insight</source><year>2021</year><volume>6</volume><fpage>e145295</fpage><pub-id pub-id-type="doi">10.1172/jci.insight.145295</pub-id><pub-id pub-id-type="pmid">33554957</pub-id><pub-id pub-id-type="pmcid">PMC7934850</pub-id></element-citation></ref><ref id="B30-metabolites-12-01205"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Fleetwood</surname><given-names>A.J.</given-names></name></person-group><article-title>Hematopoietic Progenitors and the Bone Marrow Niche Shape the Inflammatory Response and Contribute to Chronic Disease</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>23</volume><elocation-id>2234</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23042234</pub-id><pub-id pub-id-type="pmid">35216355</pub-id><pub-id pub-id-type="pmcid">PMC8879433</pub-id></element-citation></ref><ref id="B31-metabolites-12-01205"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pirillo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Svecla</surname><given-names>M.</given-names></name><name name-style="western"><surname>Catapano</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Holleboom</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Norata</surname><given-names>G.D.</given-names></name></person-group><article-title>Impact of protein glycosylation on lipoprotein metabolism and atherosclerosis</article-title><source>Cardiovasc. Res.</source><year>2021</year><volume>117</volume><fpage>1033</fpage><lpage>1045</lpage><pub-id pub-id-type="pmid">32886765</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cvr/cvaa252</pub-id></element-citation></ref><ref id="B32-metabolites-12-01205"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marchesini</surname><given-names>G.</given-names></name><name name-style="western"><surname>Brizi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bianchi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Tomassetti</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bugianesi</surname><given-names>E.</given-names></name><name name-style="western"><surname>Lenzi</surname><given-names>M.</given-names></name><name name-style="western"><surname>McCullough</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Natale</surname><given-names>S.</given-names></name><name name-style="western"><surname>Forlani</surname><given-names>G.</given-names></name><name name-style="western"><surname>Melchionda</surname><given-names>N.</given-names></name></person-group><article-title>Non-alcoholic fatty liver disease</article-title><source>Crit. Rev. Clin. Lab. Sci.</source><year>2011</year><volume>48</volume><fpage>97</fpage><lpage>113</lpage></element-citation></ref><ref id="B33-metabolites-12-01205"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saltiel</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Olefsky</surname><given-names>J.M.</given-names></name></person-group><article-title>Inflammatory mechanisms linking obesity and metabolic disease</article-title><source>J. Clin. Investig.</source><year>2017</year><volume>127</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1172/JCI92035</pub-id><pub-id pub-id-type="pmid">28045402</pub-id><pub-id pub-id-type="pmcid">PMC5199709</pub-id></element-citation></ref><ref id="B34-metabolites-12-01205"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weisberg</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>McCann</surname><given-names>D.</given-names></name><name name-style="western"><surname>Desai</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rosenbaum</surname><given-names>M.</given-names></name><name name-style="western"><surname>Leibel</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Ferrante</surname><given-names>A.W.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Obesity is associated with macrophage accumulation in adipose tissue</article-title><source>J. Clin. Investig.</source><year>2003</year><volume>112</volume><fpage>1796</fpage><lpage>1808</lpage><pub-id pub-id-type="doi">10.1172/JCI200319246</pub-id><pub-id pub-id-type="pmid">14679176</pub-id><pub-id pub-id-type="pmcid">PMC296995</pub-id></element-citation></ref><ref id="B35-metabolites-12-01205"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Orecchioni</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ghosheh</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Pramod</surname><given-names>A.B.</given-names></name><name name-style="western"><surname>Ley</surname><given-names>K.</given-names></name></person-group><article-title>Macrophage polarization: Different gene signatures in M1(Lps+) vs. Classically and M2(LPS-) vs. Alternatively activated macrophages</article-title><source>Front. Immunol.</source><year>2019</year><volume>10</volume><fpage>1084</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2019.01084</pub-id><pub-id pub-id-type="pmid">31178859</pub-id><pub-id pub-id-type="pmcid">PMC6543837</pub-id></element-citation></ref><ref id="B36-metabolites-12-01205"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nawaz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Aminuddin</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kado</surname><given-names>T.</given-names></name><name name-style="western"><surname>Takikawa</surname><given-names>A.</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tsuneyama</surname><given-names>K.</given-names></name><name name-style="western"><surname>Igarashi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ikutani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nishida</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Nagai</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>CD206<sup>+</sup> M2-like macrophages regulate systemic glucose metabolism by inhibiting proliferation of adipocyte progenitors</article-title><source>Nat. Commun.</source><year>2017</year><volume>8</volume><fpage>286</fpage><pub-id pub-id-type="doi">10.1038/s41467-017-00231-1</pub-id><pub-id pub-id-type="pmid">28819169</pub-id><pub-id pub-id-type="pmcid">PMC5561263</pub-id></element-citation></ref><ref id="B37-metabolites-12-01205"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schoedel</surname><given-names>K.B.</given-names></name><name name-style="western"><surname>Morcos</surname><given-names>M.N.F.</given-names></name><name name-style="western"><surname>Zerjatke</surname><given-names>T.</given-names></name><name name-style="western"><surname>Roeder</surname><given-names>I.</given-names></name><name name-style="western"><surname>Grinenko</surname><given-names>T.</given-names></name><name name-style="western"><surname>Voehringer</surname><given-names>D.</given-names></name><name name-style="western"><surname>G&#246;thert</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Waskow</surname><given-names>C.</given-names></name><name name-style="western"><surname>Roers</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gerbaulet</surname><given-names>A.</given-names></name></person-group><article-title>The bulk of the hematopoietic stem cell population is dispensable for murine steady-state and stress hematopoiesis</article-title><source>Blood</source><year>2016</year><volume>128</volume><fpage>2285</fpage><lpage>2296</lpage><pub-id pub-id-type="doi">10.1182/blood-2016-03-706010</pub-id><pub-id pub-id-type="pmid">27357698</pub-id></element-citation></ref><ref id="B38-metabolites-12-01205"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nour</surname><given-names>J.</given-names></name><name name-style="western"><surname>Moregola</surname><given-names>A.</given-names></name><name name-style="western"><surname>Svecla</surname><given-names>M.</given-names></name><name name-style="western"><surname>Da Dalt</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bellini</surname><given-names>R.</given-names></name><name name-style="western"><surname>Neyrolles</surname><given-names>O.</given-names></name><name name-style="western"><surname>Fadini</surname><given-names>G.P.</given-names></name><name name-style="western"><surname>Rombouts</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Albiero</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bonacina</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Mannose Receptor Deficiency Impacts Bone Marrow and Circulating Immune Cells during High Fat Diet Induced Obesity FigShare Dataset</article-title><source>Figshare Dataset</source><year>2022</year><pub-id pub-id-type="doi">10.6084/m9.figshare.21623523.v1</pub-id><pub-id pub-id-type="pmcid">PMC9784906</pub-id><pub-id pub-id-type="pmid">36557243</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="metabolites-12-01205-f001" orientation="portrait"><label>Figure 1</label><caption><p>Mrc1 deficiency impact on circulating immune cell subsets and bone marrow hematopoiesis during high-fat diet feeding. Circulating neutrophils (<bold>A</bold>), infiltrating monocytes (<bold>B</bold>), monocytes (<bold>C</bold>), myeloid cells (<bold>D</bold>), eosinophils (<bold>E</bold>), lymphocyte B cells, (<bold>F</bold>) and lymphocyte T cells (<bold>G</bold>) counts in WT and <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice fed an HFD for 20 weeks. Earlier hematopoietic progenitors, including long-term hematopoietic stem cells (LT-HSCs, (<bold>H</bold>)) and short-term hematopoietic stem cells (ST-HSCs, (<bold>I</bold>)), multipotent progenitors (MPPs, (<bold>J</bold>)) and common lymphoid progenitors (CLPs, (<bold>K</bold>)), common myeloid progenitors (CMPs, (<bold>L</bold>)), granulocyte-monocyte progenitors (GMPs, (<bold>M</bold>)), and granulocyte progenitors (GPs, (<bold>N</bold>)). Bone marrow distribution of pre-neutrophils (PNs, (<bold>O</bold>)), immature neutrophils (Ins, (<bold>P</bold>)), mature neutrophils (MNs, (<bold>Q</bold>)), macrophage/dendritic cell progenitors (MDPs, (<bold>R</bold>)), monocyte progenitors (MOPs, (<bold>S</bold>)), Ly6C<sup>low</sup> monocytes (<bold>T</bold>) and Ly6C<sup>high</sup> monocytes (<bold>U</bold>), and macrophages (<bold>V</bold>) were profiled in bone marrow from WT and <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice fed with an HFD for 20 weeks. Representative flow cytometry pseudocolor plots (red for higher density of cells, blue for lower) of WT and <italic toggle="yes">Mrc1</italic>-deficient mice of neutrophil differentiation subpopulations and macrophages are shown in panels (<bold>W</bold>,<bold>X</bold>). Representative immunofluorescence acquisition of femur sections stained with perilipin (left) with magnification of the outlined area (right) (<bold>Y</bold>). Adipocyte distribution per area (<bold>Z</bold>), mean count of cells per section (<bold>AA</bold>), and adipocyte area (<bold>AB</bold>) are shown. Results are expressed as mean &#177; SEM, <italic toggle="yes">n</italic> = 8&#8211;10 mice per group. * <italic toggle="yes">p</italic> &lt; 0.05; ** <italic toggle="yes">p</italic> &lt; 0.01.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="metabolites-12-01205-g001.jpg"/></fig><fig position="float" id="metabolites-12-01205-f002" orientation="portrait"><label>Figure 2</label><caption><p>Plasma proteomics profiling of <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup>and WT mice fed with an HFD for 20 weeks. (<bold>A</bold>) Percentage of significantly upregulated (red), significantly downregulated (green), and unchanged (purple) proteins in the plasma from <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup>mice compared to WT. (<bold>B</bold>) Plasma proteome volcano plot showing log2 fold of change (<italic toggle="yes">x</italic>-axis) and the &#8722;log10 <italic toggle="yes">p</italic>-value (<italic toggle="yes">y</italic>-axis) of <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice versus WT (upregulated proteins are shown in red, <italic toggle="yes">p</italic> &lt; 0.05, FC &gt; 1; downregulated proteins are shown in green, <italic toggle="yes">p</italic> &lt; 0.05, FC &lt; &#8722;1). (<bold>C</bold>) Principal component analysis (PCA) of the plasma proteome from WT (grey ellipse) and <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> (blue ellipse). (<bold>D</bold>) Dot plot showing fold of enrichment (<italic toggle="yes">x</italic>-axis) and the &#8211;log10 <italic toggle="yes">p</italic>-value (<italic toggle="yes">y</italic>-axis) of enriched pathways following KEGG database analysis. (<bold>E</bold>) The number of up- and downregulated proteins within the enriched pathways following KEGG database analysis. (<bold>F</bold>) Hierarchical clustering and heatmap showing relative protein expression values (Z-score transformed LFQ protein intensities) of significantly different proteins between WT and <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup>mice of the indicated KEGG pathways. (<bold>G</bold>) Downregulated or upregulated pathways as per Ingenuity Pathway Analysis (IPA) of plasma proteome profile of <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> compared to WT mice. Results are expressed as mean &#177; SEM, <italic toggle="yes">n</italic> = 8&#8211;10 mice per group.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="metabolites-12-01205-g002.jpg"/></fig><fig position="float" id="metabolites-12-01205-f003" orientation="portrait"><label>Figure 3</label><caption><p>Immune cell subset distribution in visceral adipose tissue and liver from <italic toggle="yes">Mrc1</italic>-deficient and WT mice fed with an HFD for 20 weeks. Macrophages (<bold>A</bold>), CCR2<sup>+</sup> monocyte-derived macrophages (<bold>B</bold>), and a representative flow cytometry plot of macrophages in WT and <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice (<bold>C</bold>) are shown. Inflammatory CD11c<sup>+</sup> macrophage count (<bold>D</bold>) and CD11c<sup>+</sup> F4/80<sup>int</sup> macrophage count (<bold>E</bold>) in the two experimental groups are shown. A representative flow cytometry plot showing CD11c<sup>+</sup> macrophages in WT and Mrc1-deficient mice is shown in panel (<bold>F</bold>). VAT counts of myeloid cells (<bold>G</bold>), monocytes (<bold>H</bold>), CCR2<sup>+</sup> infiltrating monocytes (<bold>I</bold>), CD11c<sup>+</sup> F4/80<sup>high</sup> macrophages (<bold>J</bold>), neutrophils (<bold>K</bold>), and eosinophils (<bold>L</bold>) are shown. Liver myeloid cells (<bold>M</bold>), monocytes (<bold>N</bold>) and CCR2<sup>+</sup> monocyte-derived macrophages (<bold>O</bold>), and representative plots showing neutrophils and monocyte distribution in the two experimental groups are presented in (<bold>P</bold>). Results are expressed as mean &#177; SEM, <italic toggle="yes">n</italic> = 5&#8211;10 mice per group. * <italic toggle="yes">p</italic> &lt; 0.05; ** <italic toggle="yes">p</italic> &lt; 0.01.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="metabolites-12-01205-g003.jpg"/></fig><fig position="float" id="metabolites-12-01205-f004" orientation="portrait"><label>Figure 4</label><caption><p>Immune metabolic phenotype of <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice and WT mice fed an HFD for 20 weeks. (<bold>A</bold>) Weekly body weight during 20 weeks of high-fat diet feeding for WT and <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice; (<bold>B</bold>) area under the curve AUC and (<bold>C</bold>) organ/tissue weight distribution of the VAT, SCAT, BAT, and liver from WT and <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice. (<bold>D</bold>) Representative images of hematoxylin and eosin-stained sections from left to right of visceral, subcutaneous, and brown adipose tissues from WT (first row) and <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice (second row). The mean area as um<sup>2</sup> of adipocytes within the VAT (<bold>E</bold>) and SCAT (<bold>F</bold>) for both experimental groups are presented. (<bold>G</bold>) Gene expression analysis of <italic toggle="yes">Ppara</italic>, <italic toggle="yes">Pgc1a</italic>, <italic toggle="yes">Atgl</italic>, <italic toggle="yes">Ucp1</italic> in BAT from <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> normalized to that of WT. Representative images of hematoxylin and eosin-stained sections of the liver from both experimental groups (<bold>H</bold>) and the prevalence of liver steatosis (<bold>I</bold>) are shown. (<bold>J</bold>) Dot plot showing fold of enrichment (<italic toggle="yes">x</italic>-axis) and the &#8211;log<sub>10</sub>&#160;<italic toggle="yes">p</italic>-value (<italic toggle="yes">y</italic>-axis) of enriched pathways following KEGG database analysis. Hierarchical clustering and heatmap showing relative protein expression values (Z-score transformed LFQ protein intensities) for proteins with significantly different expression in WT and <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice (non-alcoholic fatty liver disease, NAFLD (<bold>K</bold>) and other relevant pathways (<bold>L</bold>),FDR &lt; 0.05). (<bold>M</bold>) Glucose tolerance test (GTT) performed at 20 weeks of HFD feeding in WT and <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice and calculated AUC. (<bold>N</bold>) Insulin tolerance test (ITT) performed at 20 weeks of HFD feeding in WT and <italic toggle="yes">Mrc1</italic><sup>&#8722;/&#8722;</sup> mice and calculated AUC. Blood glucose levels are shown. Glycaemia was measured before i.p. glucose or insulin injection (t = 0, baseline values) and after 20, 40, 60, and 120 min. Results are expressed as mean &#177; SEM, <italic toggle="yes">n</italic> = 8&#8211;10 mice per group. * <italic toggle="yes">p</italic> &lt; 0.05; ** <italic toggle="yes">p</italic> &lt; 0.01.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="metabolites-12-01205-g004.jpg"/></fig></floats-group></article></pmc-articleset>